JP2008545686A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545686A5
JP2008545686A5 JP2008513411A JP2008513411A JP2008545686A5 JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5 JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5
Authority
JP
Japan
Prior art keywords
methoxy
dimethylamino
dihydro
chromen
tetrahydronaphthalen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2006/000593 external-priority patent/WO2006126939A1/en
Publication of JP2008545686A publication Critical patent/JP2008545686A/ja
Publication of JP2008545686A5 publication Critical patent/JP2008545686A5/ja
Pending legal-status Critical Current

Links

JP2008513411A 2005-05-23 2006-05-22 5ht6受容体を調節する新規な8−スルホニルアミノ−3アミノ置換クロマンまたはテトラヒドロナフタレン誘導体 Pending JP2008545686A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0501166 2005-05-23
SE0501168 2005-05-23
PCT/SE2006/000593 WO2006126939A1 (en) 2005-05-23 2006-05-22 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor

Publications (2)

Publication Number Publication Date
JP2008545686A JP2008545686A (ja) 2008-12-18
JP2008545686A5 true JP2008545686A5 (enExample) 2009-07-09

Family

ID=37452274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513411A Pending JP2008545686A (ja) 2005-05-23 2006-05-22 5ht6受容体を調節する新規な8−スルホニルアミノ−3アミノ置換クロマンまたはテトラヒドロナフタレン誘導体

Country Status (13)

Country Link
US (1) US20090030038A1 (enExample)
EP (1) EP1888517A1 (enExample)
JP (1) JP2008545686A (enExample)
KR (1) KR20080016810A (enExample)
AR (1) AR054363A1 (enExample)
AU (1) AU2006250117A1 (enExample)
BR (1) BRPI0610119A2 (enExample)
CA (1) CA2609747A1 (enExample)
IL (1) IL187099A0 (enExample)
MX (1) MX2007014263A (enExample)
NO (1) NO20076638L (enExample)
TW (1) TW200716529A (enExample)
WO (1) WO2006126939A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7727473B2 (en) 2005-10-19 2010-06-01 Progentech Limited Cassette for sample preparation
US7754148B2 (en) 2006-12-27 2010-07-13 Progentech Limited Instrument for cassette for sample preparation
US8299267B2 (en) 2007-09-24 2012-10-30 Comentis, Inc. (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
AU2008331920A1 (en) 2007-12-04 2009-06-11 Merck Sharp & Dohme Corp. Tryptamine sulfonamides as 5-HT6 antagonists
EP2116546A1 (en) 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands
EP2116547A1 (en) 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands
WO2011106384A1 (en) 2010-02-23 2011-09-01 Genturadx, Inc. Apparatus and methods for integrated sample preparation, reaction and detection
US9248422B2 (en) 2010-02-23 2016-02-02 Luminex Corporation Apparatus and methods for integrated sample preparation, reaction and detection
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
JP5641436B2 (ja) * 2011-03-28 2014-12-17 国立大学法人 鹿児島大学 抗hiv薬
US9840482B2 (en) 2014-04-19 2017-12-12 Sunshine Lake Pharma Co., Ltd. Sulfonamide derivatives and pharmaceutical applications thereof
CA2957566C (en) 2014-08-12 2023-08-01 Daniel Paul Becker Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same
HUE067314T2 (hu) 2017-09-22 2024-10-28 Jubilant Epipad LLC Heterociklusos vegyületek mint PAD gátlók
KR102782563B1 (ko) 2017-10-18 2025-03-14 주빌런트 에피파드 엘엘씨 Pad 억제제로서의 이미다조-피리딘 화합물
KR20200085836A (ko) 2017-11-06 2020-07-15 주빌런트 프로델 엘엘씨 Pd1/pd-l1 활성화 억제제로서의 피리미딘 유도체
BR112020010322A2 (pt) 2017-11-24 2020-11-17 Jubilant Episcribe Llc composto da fórmula i; composto da fórmula ia; composto da fórmula ib; processo de preparação de compostos da fórmula i; composição farmacêutica; método para o tratamento e/ou prevenção de várias doenças; uso dos compostos; método para o tratamento de câncer; e método para o tratamento e/ou prevenção de uma afecção mediada por prmt5 ou um distúrbio proliferativo ou câncer
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
CH637363A5 (en) * 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
PL338016A1 (en) * 1997-07-11 2000-09-25 Smithkline Beecham Plc Novel chemical compounds
JP2005505586A (ja) * 2001-10-04 2005-02-24 ワイス 5−ヒドロキシトリプタミン−6リガンドとしてのクロマン誘導体
NZ589649A (en) * 2004-10-14 2012-04-27 Abbott Gmbh & Co Kg Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Similar Documents

Publication Publication Date Title
JP2008545686A5 (enExample)
US6515002B2 (en) Compounds and compositions for treating C1s-mediated diseases and conditions
CA2787121C (en) Aminopyridine derivatives as anti-malarial agents
RU2576036C2 (ru) Модуляторы активности нес1 и способы для них
RU2007107189A (ru) Производные арилпиридина
RU2011147185A (ru) Азетидинилдиамиды в качестве ингибиторов моноацилглицерин-липазы
JP2013517273A5 (enExample)
TWI691475B (zh) Urat1抑制劑
JP2013525293A5 (enExample)
JP2008524244A5 (enExample)
TW201522306A (zh) 雜環衍生物及其用途
JP2005505586A5 (enExample)
WO2002028353A2 (en) Phosphate transport inhibitors
RU2007107349A (ru) Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств
JP2005514432A5 (enExample)
JP2003531201A (ja) 炎症を治療するための2−フルオロベンゼンスルホニル化合物
CA2582276A1 (en) Alkil-pyridines as 11-beta inhibitors for diabetes
JP2002536446A (ja) プロテアーゼ阻害剤としての、ヘテロアリールアミジン類、メチルアミジン類およびグアニジン類
CA2859024C (en) Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators
US9603834B2 (en) 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
JP2016518428A5 (enExample)
JP2008115166A5 (enExample)
CN101203504B (zh) 抗微生物剂
RU2007131275A (ru) Производные n-[(4, 5-дифенил-2-тиенил)метил]сульфонамида, их получение и их применение в терапии
JP2009533315A (ja) 抗菌剤